The efficacy and safety of Rifaximin in the management of hepatic encephalopathy

Mohannad Ali Alghamdi; Hassan Abdulrahman Eissa

doi:10.24911/IJMDC.51-1548629244

2024, Vol: 8, Issue: 4

8 / 4Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

« Previous Article

Review Article

Online Publishing Date:
10 / 02 / 2019

IJMDC. 2020; 4(9): 1491-1494

doi: 10.24911/IJMDC.51-1548629244

The efficacy and safety of Rifaximin in the management of hepatic encephalopathy

Mohannad Ali Alghamdi, Hassan Abdulrahman Eissa.

Abstract
Hepatic encephalopathy (HE) is a clinical condition that results in the decline of brain function as a result of severe liver disease. Rifaximin is an antibiotic of non-absorbable nature that is derived from rifamycin used for the HE treatment. The aim of this review was to determine the efficacy, safety, and outcomes of rifaximin in the treatment of HE. A systematic search was performed using PubMed database for clinical trials involving rifaximin and treatment of hepatic encephalopathy. Specific keywords were employed to obtain all possible results during the systematic research. The option to include clinical trials was selected in the database home screen to limit the search to clinical trials. The present study reviewed and analyzed five clinical trials that were published between the year 2010 and 2016. The selected studies were summarized based on the abstract of the study; author and publication year, study design, sample size, type of diagnosis, treatment regimen, and major findings. The current study found that rifaximin can be used for the treatment of minimal HE and HE. One dose of rifaximin is preferred for the treatment of HE, whereas in overt HE the combination therapy is the choice of the preference.

Key words: HE treatment, rifaximin, clinical trials, rifaximin efficacy

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Mohannad Ali Alghamdi Articles by Hassan Abdulrahman Eissa
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Alghamdi MA, Eissa HA. The efficacy and safety of Rifaximin in the management of hepatic encephalopathy. IJMDC. 2020; 4(9): 1491-1494. doi:10.24911/IJMDC.51-1548629244

Web Style

Alghamdi MA, Eissa HA. The efficacy and safety of Rifaximin in the management of hepatic encephalopathy. https://www.ijmdc.com/?mno=28203 [Access: March 26, 2024]. doi:10.24911/IJMDC.51-1548629244

AMA (American Medical Association) Style

Alghamdi MA, Eissa HA. The efficacy and safety of Rifaximin in the management of hepatic encephalopathy. IJMDC. 2020; 4(9): 1491-1494. doi:10.24911/IJMDC.51-1548629244

Vancouver/ICMJE Style

Alghamdi MA, Eissa HA. The efficacy and safety of Rifaximin in the management of hepatic encephalopathy. IJMDC. (2020), [cited March 26, 2024]; 4(9): 1491-1494. doi:10.24911/IJMDC.51-1548629244

Harvard Style

Alghamdi, M. A. & Eissa, . H. A. (2020) The efficacy and safety of Rifaximin in the management of hepatic encephalopathy. IJMDC, 4 (9), 1491-1494. doi:10.24911/IJMDC.51-1548629244

Turabian Style

Alghamdi, Mohannad Ali, and Hassan Abdulrahman Eissa. 2020. The efficacy and safety of Rifaximin in the management of hepatic encephalopathy. International Journal of Medicine in Developing Countries, 4 (9), 1491-1494. doi:10.24911/IJMDC.51-1548629244

Chicago Style

Alghamdi, Mohannad Ali, and Hassan Abdulrahman Eissa. "The efficacy and safety of Rifaximin in the management of hepatic encephalopathy." International Journal of Medicine in Developing Countries 4 (2020), 1491-1494. doi:10.24911/IJMDC.51-1548629244

MLA (The Modern Language Association) Style

Alghamdi, Mohannad Ali, and Hassan Abdulrahman Eissa. "The efficacy and safety of Rifaximin in the management of hepatic encephalopathy." International Journal of Medicine in Developing Countries 4.9 (2020), 1491-1494. Print. doi:10.24911/IJMDC.51-1548629244

APA (American Psychological Association) Style

Alghamdi, M. A. & Eissa, . H. A. (2020) The efficacy and safety of Rifaximin in the management of hepatic encephalopathy. International Journal of Medicine in Developing Countries, 4 (9), 1491-1494. doi:10.24911/IJMDC.51-1548629244

Most Viewed Articles

Most Accessed Articles

Marginal adaptation of fixed prosthodontics
Shahad Mohammed Halawani, Sahar Amer Al-Harbi
IJMDC. 2017; 1(2): 78-84
» Abstract » doi: 10.24911/IJMDC.1.2.7

Parasites in central nervous system
Amal Ahmed Mohamed, Asmaa Mohamed Mansour
IJMDC. 2017; 1(2): 72-77
» Abstract » doi: 10.24911/IJMDC.1.2.6

Non-diabetic retinopathy: a case report
Hassan F. Alkwikbi, Nabil Mamon Abdelfattah, Haithem Mamon Abdelfattah
IJMDC. 2017; 1(1): 33-37
» Abstract » doi: 10.24911/IJMDC.1.1.6

Vitamin D deficiency among high school female students in Riyadh
Sahar Mohsen Aldhafeeri, Fatemah Ibraheem Alrawaji, Abrar Mubarak Algharbi, Alanoud Abdullah Alhessan, Ayat Sami Qabaja, Ghaleah Abdulaziz Alnassar, Ghaliah Ofayn Alsulami, Mashael Belal Alrubaian, Norah Abdulaziz Alhatim, Salehah Salih Alotaibi, Zahra Ali Alkhamees
IJMDC. 2017; 1(1): 18-23
» Abstract » doi: 10.24911/IJMDC.1.1.4

Prognosis of chronic complications of diabetes mellitus (DM) after multiple events of diabetic ketoacidosis (DKA)
Baraa Faiez Rajab, Anwar Essa Alamrim, Ali Essa Alamri
IJMDC. 2019; 3(5): 474-479
» Abstract » doi: 10.24911/IJMDC.51-1546551993

Most Downloaded

Top Downloaded Articles

Anti-IL-17 markedly inhibited the in vitro granuloma induced by Schistosoma mansoni soluble egg antigen.
Asmaa Ezz, Irene S. Gmail, Fatma Elzahraa H. Salem, Rabab Salama, Soad Nady
IJMDC. 2018; 2(January 2018): 38-46
» Abstract » doi: 10.24911/IJMDC.2.1.7

Antibiotic Resistance Crisis
Nuha Saad Mobarki, Buthaina Abdullah Almerabi, Ahmad Hattan Hattan
IJMDC. 2019; 3(6): 561-564
» Abstract » doi: 10.24911/IJMDC.51-1549060699

The knowledge of mothers about children malnutrition and associated factors
Anas Abdulrahman Aljohani, Mujahid Abdulrahman Aljohani
IJMDC. 2020; 4(1): 7-11
» Abstract » doi: 10.24911/IJMDC.51-1541620358

Knowledge and attitude of caregivers of cerebral palsy children in Riyadh city
Abdulaziz Alruwaished, Baleegh Ali, Lubna Abdullah Alhowaimil , Abaraa adullah Alhowaimil, Najd Abdullah Alhowaimil, Aminah Alessa
IJMDC. 2020; 4(1): 12-17
» Abstract » doi: 10.24911/IJMDC.51-1547833051

Most Cited Articles

Most Cited Articles

Antibiotic Resistance Crisis
Nuha Saad Mobarki, Buthaina Abdullah Almerabi, Ahmad Hattan Hattan
IJMDC. 2019; 3(6): 561-564
» Abstract » doi: 10.24911/IJMDC.51-1549060699
Cited : 34 times [Click to see citing articles]

Prevalence of depression, anxiety and stress among diabetes mellitus patients in Arar, Northern Saudi Arabia
AMohammed Elamin Mukrim, Nujud Muteb D. Alshammari, Wurud Muteb D. Alshammari, Maali Subhi T. Alshammari, Yousef Nasif R. Alshammari, Abdulaziz Sael M. Alshammari, Maisa Hamad F. Alanazi, Abdulelah Abdulrhman F. Alzammam, Muharib Mana M. Alshammari, Slwa Khaled Abu Asyah, Aseel Jamal Alzuhayri, Mushref Saeid Alshammari
IJMDC. 2019; 3(3): 229-233
» Abstract » doi: 10.24911/IJMDC.51-1542576396
Cited : 8 times [Click to see citing articles]

Knowledge, attitude, and practice of breast self-examination toward breast cancer among female students at King Saud University in Riyadh, Saudi Arabia
Abdullah Nasser Alomair, Dania Ghazi Felemban, Mohannad Sami Felemban, Jameel Abdullah Awadain, Ammar Saud Altowairqi, Nawaf Fawzan Alfawzan, Fatimah Mohammed Almazayen, Abdulrahman Jalwi Korkoman, Nawaf Saad Alrusayyis
IJMDC. 2020; 4(2): 429-434
» Abstract » doi: 10.24911/IJMDC.51-1576668182
Cited : 8 times [Click to see citing articles]

Population awareness about rheumatoid arthritis in Jazan region, Saudi Arabia
Ahmad Ali Hazzazi, Mohssen Hassen Ageeli, Ahmed Ali Muyidi, Abdulaziz Mohammad Abulgasim, Abdullah Ahmad Yateemi, Nabil Alhakami
IJMDC. 2020; 4(3): 668-675
» Abstract » doi: 10.24911/IJMDC.51-1576010943
Cited : 4 times [Click to see citing articles]

Prevalence and factors associated with depression among health care workers in National Guard Hospital in Riyadh, KSA
Noor Mohammad AlFahhad
IJMDC. 2018; 2(September 2018): 92-96
» Abstract » doi: 10.24911/IJMDC.51-1526306040
Cited : 4 times [Click to see citing articles]

About International Journal of Medicine in Developing Countries

Contact Information

How to cite this article